PELAIA, CORRADO
 Distribuzione geografica
Continente #
NA - Nord America 675
EU - Europa 321
AS - Asia 25
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 2
Totale 1.031
Nazione #
US - Stati Uniti d'America 667
IT - Italia 192
DE - Germania 42
GB - Regno Unito 30
SE - Svezia 29
IN - India 11
CA - Canada 8
FR - Francia 8
FI - Finlandia 7
AU - Australia 5
IE - Irlanda 5
CN - Cina 4
ES - Italia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
EG - Egitto 2
HK - Hong Kong 2
CY - Cipro 1
EU - Europa 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
JP - Giappone 1
MY - Malesia 1
PK - Pakistan 1
PT - Portogallo 1
RO - Romania 1
RU - Federazione Russa 1
SG - Singapore 1
TR - Turchia 1
Totale 1.031
Città #
Chandler 134
Princeton 58
Lawrence 57
Catanzaro 41
Wilmington 35
London 26
Ashburn 25
Chicago 25
Des Moines 14
Troina 11
Florence 9
Norwalk 9
Palermo 8
Helsinki 7
Redmond 7
Redwood City 7
Castrovillari 6
Naples 6
Ottawa 6
Cosenza 5
Dublin 5
Hanover 5
Seattle 5
Indore 4
Providence 4
Bari 3
Houston 3
Lamezia Terme 3
Mascalucia 3
Milan 3
Padova 3
Pune 3
Turin 3
Aversa 2
Brookline 2
Campbelltown 2
Foggia 2
Girona 2
Marseille 2
Mendicino 2
Messina 2
Mountain View 2
Nagold 2
Paris 2
Phoenix 2
Qalyubia 2
Rome 2
Treviso 2
West Jordan 2
Aiello Calabro 1
Amantea 1
Anchorage 1
Ankara 1
Ann Arbor 1
Ardabil 1
Augusta 1
Beijing 1
Boardman 1
Bollebygd 1
Brampton 1
Brisbane 1
Budapest 1
Cachan 1
Cagliari 1
Calgary 1
Clearwater 1
Cochranville 1
Cupertino 1
Esslingen am Neckar 1
Fayetteville 1
Fiumicino 1
Furtei 1
Grottaferrata 1
Guangzhou 1
Herzliya 1
Islamabad 1
Karlsruhe 1
Kuala Lumpur 1
Lessolo 1
Lutzingen 1
Man Kok 1
Manchester 1
Melbourne 1
Mem Martins 1
Modena 1
New York 1
Novokuznetsk 1
Nuremberg 1
Polistena 1
Reggio Emilia 1
Reno 1
San Francisco 1
San Mateo 1
Sellia Marina 1
Settle 1
Sezze 1
Sindelfingen 1
Singapore 1
Siziano 1
Stockholm 1
Totale 626
Nome #
An Analytical Method for Assessing Optimal Storage Conditions of Gingival Crevicular Fluid and Disclosing a Peptide Biomarker Signature of Gingivitis by MALDI-TOF MS 45
Hexagonal Mesoporous Silica as a Rapid, Efficient and Versatile Tool for MALDI-TOF MS Sample Preparation in Clinical Peptidomics Analysis: A Pilot Study. 34
MALDI MS-Based Investigations Targeting SARS-CoV-2 34
Biological mechanisms underlying the clinical effects of allergen-specific immunotherapy in asthmatic children 31
Comparisons of two diaphragm ultrasound-teaching programs: a multicenter randomized controlled educational study. 29
Real-life rapidity of benralizumab effects in patients with severe allergic eosinophilic asthma: Assessment of blood eosinophils, symptom control, lung function and oral corticosteroid intake after the first drug dose 29
Benralizumab: From the basic mechanism of action to the potential use in the biological therapy of severe eosinophilic asthma 28
Rapid detection and identification of antimicrobial peptide fingerprints of nasal fluid by mesoporous silica particles and MALDI-TOF/TOF mass spectrometry: from the analytical approach to the diagnostic applicability in precision medicine 27
Effects of the first three doses of benralizumab on symptom control, lung function, blood eosinophils, oral corticosteroid intake, and nasal polyps in a patient with severe allergic asthma 26
Uric acid and vascular damage in essential hypertension: Role of insulin resistance 26
Association Between Sleep Apnea and Valvular Heart Diseases 26
Effects of Sacubitril-Valsartan on Clinical, Echocardiographic, and Polygraphic Parameters in Patients Affected by Heart Failure With Reduced Ejection Fraction and Sleep Apnea 24
Benralizumab: From the basic mechanism of action to the potential use in the biological therapy of severe eosinophilic asthma 24
Clinical relevance of understanding mitogen-activated protein kinases involved in asthma 23
Gingival Crevicular Fluid Peptidome Profiling in Healthy and in Periodontal Diseases. 21
Biologics in severe asthma 21
New treatments for asthma: From the pathogenic role of prostaglandin D2 to the therapeutic effects of fevipiprant 20
Nasal polyposis: Insights in epithelial-mesenchymal transition and differentiation of polyp mesenchymal stem cells 20
Mapping the SARS-CoV-2–host protein–protein interactome by affinity purification mass spectrometry and proximity-dependent biotin labeling: A rational and straightforward route to discover host-directed anti-SARS-CoV-2 therapeutics 20
Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: Results of a 5-YEAR single-centre observational study 20
Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study 18
Short term effect of sacubitril/valsartan on comprehensive geriatric assessment in chronic heart failure: a real life analysis 18
Real-Life Clinical and Functional Effects of Fluticasone Furoate/Umeclidinium/Vilanterol-Combined Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease 18
High-flow nasal cannula oxygen therapy for outpatients undergoing flexible bronchoscopy: a randomised controlled trial 18
Real-Life effects of benralizumab on exacerbation number and lung hyperinflation in atopic patients with severe eosinophilic asthma 17
Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study 17
Current Practice of High Flow through Nasal Cannula in Exacerbated COPD Patients 16
Clinical and economic consequences of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma 16
Electrical impedance tomography during spontaneous breathing trials and after extubation in critically ill patients at high risk for extubation failure: a multicenter observational study. 15
Tezepelumab: A potential new biological therapy for severe refractory asthma 15
Patient-ventilator asynchrony in adult critically ill patients 15
Predictors of renal function worsening in patients with chronic obstructive pulmonary disease (Copd): A multicenter observational study 15
Short-term evaluation of dupilumab effects in patients with severe asthma and nasal polyposis 15
Spotlight on a Short-Time Treatment with the IL-4/IL-13 Receptor Blocker in Patients with CRSwNP: microRNAs Modulations and Preliminary Clinical Evidence 15
Severe Eosinophilic Asthma: from the Pathogenic role of Interleukin-5 to the Therapeutic Action of Mepolizumab. 14
Real-life effects of benralizumab on allergic chronic rhinosinusitis and nasal polyposis associated with severe asthma 14
Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub-phenotypes of response identified by cluster analysis 14
Asthma control during COVID-19 lockdown in patients with severe asthma under biological drug treatment 14
What is the Role of Sex-Related Differences in the Effectiveness and Safety of Biological Drugs used in Patients' Severe Asthma? 13
Primary mucosal melanoma presenting with a unilateral nasal obstruction of the left inferior turbinate 13
Intraoperative protective ventilation in patients undergoing major neurosurgical interventions: a randomized clinical trial 13
Association between right ventricular dysfunction and adverse cardiac events in mild COPD patients 12
Role of p38-mitogen-activated protein kinase in COPD: pathobiological implications and therapeutic perspectives 12
Intrinsic laryngeal lipoma treated with transoral Co2 laser microsurgery: An unusual case report 12
Biological Therapy of Severe Asthma with Dupilumab, a Dual Receptor Antagonist of Interleukins 4 and 13 11
Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets 11
Nurse led protocols for control of glycaemia in critically ill patients: A systematic review 11
Real-life effectiveness of mepolizumab on forced expiratory flow between 25% and 75% of forced vital capacity in patients with severe eosinophilic asthma 11
MALDI MS-Based Investigations for SARS-CoV-2 Detection 10
Biologicals decrease psychological distress, anxiety and depression in severe asthma, despite Covid-19 pandemic 9
Efficacy and safety of first-line checkpoint inhibitors-based treatments for non-oncogene-addicted non-small-cell lung cancer: a systematic review and meta-analysis 9
Monoclonal antibodies targeting alarmins: A new perspective for biological therapies of severe asthma 9
Indacaterol/glycopyrronium/mometasone fixed dose combination for uncontrolled asthma 9
Effect of Statins on Lung Cancer Molecular Pathways: A Possible Therapeutic Role 8
Mechanical ventilation in brain injured patients: seeing the forest for the trees 8
Switching from omalizumab to mepolizumab: real-life experience from Southern Italy 8
Pharmacotherapeutic strategies for critical asthma syndrome: a look at the state of the art 8
Switch from omalizumab to benralizumab in allergic patients with severe eosinophilic asthma: A real-life experience from Southern Italy 8
Mepolizumab effectiveness on small airway obstruction, corticosteroid sparing and maintenance therapy step-down in real life 7
Phenotyping severe asthma: a rationale for biologic therapy 7
Interleukin-5 in the Pathophysiology of Severe Asthma 7
Molecular Targets for Biological Therapies of Severe Asthma 7
Role of p38 mitogen-activated protein kinase in asthma and COPD: Pathogenic aspects and potential targeted therapies 7
Oxygenation strategies during flexible bronchoscopy: a review of the literature 7
Assessment of cephalometric parameters and correlation with the severity of the obstructive sleep apnea syndrome 6
Novel Biological Therapies for Severe Asthma Endotypes 6
Benefits of secretion clearance with high frequency percussive ventilation in tracheostomized critically ill patients: a pilot study 6
Real-life Mepolizumab effectiveness in severe eosinophilic asthmatics with nasal polyposis 6
Therapeutic effects of benralizumab assessed in patients with severe eosinophilic asthma: Real-life evaluation correlated with allergic and non-allergic phenotype expression 6
Mepolizumab Effectiveness and Allergic Status in Real Life 6
Novel Biological Therapies for Severe Asthma Endotypes 5
Effects of continuous positive airway pressure on comprehensive geriatric assessment and cognitive function in elderly patients with obstructive sleep apnea syndrome 5
Real-life evaluation of mepolizumab efficacy in patients with severe eosinophilic asthma, according to atopic trait and allergic phenotype 5
Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications 5
Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence. 5
New potential biomarkers for early chronic kidney disease diagnosis in patients with different glucose tolerance status 4
Clinical and Functional Effects of Inhaled Dual Therapy Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease: A Real-Life Study 3
Difficult-To-Treat and Severe Asthma: Can Real-World Studies On Effectiveness of Biological Treatments Change the Lives of Patients? 3
Cost-Sensitive Models to Predict Risk of Cardiovascular Events in Patients with Chronic Heart Failure 3
Real-Life Effects of Omalizumab on Chronic Rhinosinusitis with Nasal Polyposis 3
Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study 2
Effects of High-Flow Nasal Cannula on Right Heart Dysfunction in Patients with Acute-on-Chronic Respiratory Failure and Pulmonary Hypertension 2
Association between non-dipping blood pressure pattern and different glucometabolic profile during oral glucose tolerance test 2
Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience 2
Targeting IL-4 and IL-13 Receptors on Eosinophils in CRSwNP Patients: The Clinical Efficacy of Dupilumab 1
Real-life therapeutic effects of beclomethasone dipropionate/formoterol fumarate/glycopyrronium combined triple therapy in patients with chronic obstructive pulmonary disease 1
Real-world characteristics of “super-responders” to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis 1
Effectiveness of glycopyrronium bromide in the treatment of small airway dysfunction: A retrospective study 1
Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps 1
An integrated metabo-lipidomics profile of induced sputum for the identification of novel biomarkers in the differential diagnosis of asthma and COPD 1
TSLP and HMGB1: Inflammatory Targets and Potential Biomarkers for Precision Medicine in Asthma and COPD 1
Benralizumab Effectiveness in Severe Eosinophilic Asthma with Co-Presence of Bronchiectasis: A Real-World Multicentre Observational Study 1
Do Comorbidities Influence the Response to Biologics in Severe Asthma? 1
Publisher Correction to: An integrated metabo‑lipidomics profile of induced sputum for the identification of novel biomarkers in the differential diagnosis of asthma and COPD 1
Effects of inhaled beclomethasone dipropionate/formoterol fumarate/glycopyrronium on diaphragmatic workload and lung function in uncontrolled asthma: a case report 1
Totale 1.155
Categoria #
all - tutte 15.465
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.465


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202031 0 0 0 0 6 1 0 2 0 0 4 18
2020/2021121 2 0 5 9 22 11 3 4 49 8 5 3
2021/2022214 4 3 32 27 6 7 22 34 28 18 32 1
2022/2023511 121 30 40 9 52 46 26 38 59 25 44 21
2023/2024278 57 40 31 24 11 63 6 15 5 24 2 0
Totale 1.155